Open AccessIntrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in ‘anti‐programmed cell death protein 1 antibody‐induced’ fulminant type 1 diabetes
Author(s) -
Sakai Gota,
Saito Daigo,
Nakajima Ritsuko,
Hatano Masako,
Noguchi Yuichi,
Kurihara Susumu,
Katayama Shigehiro,
Inoue Ikuo,
Noda Mitsuhiko,
Shimada Akira
Publication year - 2018
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.12662
Subject(s) - medicine , fulminant , type 1 diabetes , type 2 diabetes , nivolumab , antibody , autoantibody , endocrinology , diabetes mellitus , insulin , immunology , immunotherapy , cancer
Intrinsic insulin secretion capacity may be preserved by discontinuing anti‐PD‐1 antibody treatment in ‘anti‐PD‐1 antibody‐induced‘fulminant type 1 diabetes.